ArticleImmunity, inflammation and disease2021

Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.

Archana Kulkarni-Munje et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.